Boehnlein Glenn S
SEC CIK 1670936 · EDGAR
BoughtSold
Most active insiders at DXCM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SAYER KEVIN R | Executive COB, Dir | — | $8.30M |
| 2 | Leach Jacob Steven | Pres, COO | $1.00M | — |
| 3 | Brown Michael Jon | EVP, CLO | — | $873.4K |
| 4 | Coleman Jon | EVP, Chief Commercial Off | — | $722.6K |
| 5 | AUGUSTINOS NICHOLAS | Dir | — | $679.8K |
| 6 | FOLETTA MARK G | Dir | — | $627.2K |
| 7 | Collins Richard Alexander | Dir | — | $389.4K |
| 8 | Sylvain Jereme M | EVP, Chief Financal Off | — | $302.9K |
| 9 | Heller Bridgette P | Dir | — | $277.7K |
| 10 | Stern Sadie | EVP, Chief HR Off | — | $226.7K |
| 15 | Boehnlein Glenn S | Dir | — | — |
Transactions 44
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 16:40 | 2026-09-10 | DXCM | Dexcom | Boehnlein Glenn S | Dir | A - Grant | $0.00 | +5,841 | 5,841 | New | $0 | |
| 2026-09-10 08:52 | 2026-09-08 | A | Agilent Technologies | Boehnlein Glenn S | Dir | A - Grant | $146.85 | +817 | 817 | New | +$120.0K | |
| 2026-06-09 16:21 | 2026-06-05 | INGN | Inogen Inc | Boehnlein Glenn S | Dir | A - Grant | $0.00 | +28.1K | 105.0K | +37% | $0 | |
| 2025-05-19 | 2025-05-14 | INGN | Inogen Inc | Boehnlein Glenn S | Dir | A - Grant | $0.00 | +30.6K | 76.9K | +66% | $0 | |
| D | 2025-03-25 | 2025-03-21 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $0.00 | +314 | 18.4K | +2% | $0 |
| D | 2025-03-25 | 2025-03-21 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $374.22 | -6,720 | 11.6K | -37% | -$2.51M |
| 2025-03-12 | 2025-03-10 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | A - Grant | $0.00 | +12.9K | 18.0K | +252% | $0 | |
| D | 2025-01-02 | 2024-12-31 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $122.51 | +300 | 5,331 | +6% | +$36.8K |
| D | 2025-01-02 | 2024-12-31 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $362.26 | -203 | 5,128 | -4% | -$73.5K |
| D | 2024-12-30 | 2024-12-27 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $122.51 | +2,000 | 6,373 | +46% | +$245.0K |
| D | 2024-12-30 | 2024-12-27 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $369.42 | -1,342 | 5,031 | -21% | -$495.8K |
| D | 2024-11-19 | 2024-11-18 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $122.51 | +4,500 | 7,352 | +158% | +$551.3K |
| D | 2024-11-19 | 2024-11-18 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $390.08 | -2,979 | 4,373 | -41% | -$1.16M |
| 2024-08-02 | 2024-08-02 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | S - Sale | $333.00 | -20.0K | 2,852 | -88% | -$6.66M | |
| D | 2024-07-03 | 2024-07-02 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $122.51 | +25.0K | 40.0K | +167% | +$3.06M |
| D | 2024-07-03 | 2024-07-02 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $336.50 | -17.2K | 22.9K | -43% | -$5.77M |
| 2024-06-07 | 2024-06-05 | INGN | Inogen Inc | Boehnlein Glenn S | Dir | A - Grant | $0.00 | +21.9K | 46.3K | +90% | $0 | |
| 2024-05-16 | 2024-05-15 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | S - Sale | $327.65 | -10.0K | 15.0K | -40% | -$3.28M | |
| 2024-05-03 | 2024-05-01 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $336.50 | -585 | 25.0K | -2% | -$196.9K | |
| D | 2024-03-25 | 2024-03-21 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $0.00 | +256 | 31.2K | +0.8% | $0 |
| D | 2024-03-25 | 2024-03-21 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $353.19 | -5,555 | 25.6K | -18% | -$1.96M |
| 2024-03-13 | 2024-03-11 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | A - Grant | $0.00 | +10.7K | 30.9K | +53% | $0 | |
| 2024-02-12 | 2024-02-09 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | S - Sale | $342.81 | -9,600 | 20.2K | -32% | -$3.29M | |
| D | 2024-01-16 | 2024-01-11 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $307.78 | -39.2K | 29.8K | -57% | -$12.06M |
| DM | 2024-01-16 | 2024-01-11 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $95.99 | +60.0K | 69.0K | +669% | +$5.76M |
| D | 2023-11-28 | 2023-11-27 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $81.14 | +12.0K | 16.6K | +259% | +$970.0K |
| D | 2023-11-28 | 2023-11-27 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $293.64 | -7,594 | 8,976 | -46% | -$2.23M |
| 2023-06-02 | 2023-05-31 | INGN | Inogen Inc | Boehnlein Glenn S | Dir | A - Grant | $0.00 | +17.1K | 24.4K | +234% | $0 | |
| 2023-05-03 | 2023-05-01 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $299.65 | -572 | 4,615 | -11% | -$171.4K | |
| D | 2023-03-23 | 2023-03-21 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $0.00 | +149 | 7,902 | +2% | $0 |
| D | 2023-03-23 | 2023-03-21 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $276.83 | -2,715 | 5,187 | -34% | -$751.6K |
| 2023-03-09 | 2023-03-07 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | A - Grant | $0.00 | +5,325 | 7,753 | +219% | $0 | |
| M | 2023-02-06 | 2023-02-02 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | S - Sale | $278.54 | -24.4K | 2,553 | -91% | -$6.80M |
| D | 2023-01-12 | 2023-01-11 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $64.01 | +14.5K | 35.3K | +70% | +$929.1K |
| D | 2023-01-12 | 2023-01-11 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $263.81 | -8,433 | 26.9K | -24% | -$2.22M |
| 2022-06-10 | 2022-06-08 | INGN | Inogen Inc | Boehnlein Glenn S | Dir | A - Grant | $0.00 | +6,849 | 7,308 | +1,492% | $0 | |
| D | 2022-05-03 | 2022-05-01 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $241.26 | -572 | 18.4K | -3% | -$138.0K |
| D | 2022-05-03 | 2022-05-01 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $0.00 | +1,210 | 18.9K | +7% | $0 |
| 2022-03-24 | 2022-03-22 | INGN | Inogen Inc | Boehnlein Glenn S | Dir | A - Grant | $0.00 | +459 | 459 | New | $0 | |
| D | 2022-03-23 | 2022-03-21 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $267.34 | -4,116 | 17.7K | -19% | -$1.10M |
| D | 2022-03-23 | 2022-03-21 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $0.00 | +8,723 | 21.8K | +67% | $0 |
| D | 2022-03-14 | 2021-12-21 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | M - OptEx | $0.00 | +170 | 13.3K | +1% | $0 |
| D | 2022-03-14 | 2021-12-21 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | F - Tax | $247.77 | -170 | 13.1K | -1% | -$42.1K |
| M | 2021-12-14 | 2021-12-10 | SYK | Stryker Corporation | Boehnlein Glenn S | VP, CFO | S - Sale | $259.79 | -2,778 | 13.7K | -17% | -$721.7K |
Purchase Sale Sale after option exercise All abbreviations